Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis exploratory results from a randomised, double-blind, placebo-contr...

Ridker Paul M., MacFadyen Jean G., Thuren Tom, Everett Brendan M., Libby Peter, Glynn Robert J., CANTOS Trial Group, Forster Tamás, Ridker Paul, Lorenzatti Alberto, Krum Henry, Varigos John, Siostrzonek Peter, Sinnaeve Peter, Fonseca Francisco, et al
2017

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab a secondary analysis from the CANTOS randomised controlled trial...

Ridker Paul M., MacFadyen Jean G., Everett Brendan M., Libby Peter, Thuren Tom, Glyn Robert J., Kollaborációs szervezet: CANTOS Trial Group, Kastelein John, Koenig Wolfgang, Genest Jacques, Lorenzatti Alberto, Varigos John, Siostrzonek Peter, Sinnaeve Peter, Fonseca Francisco, Forster Tamás
2018